Pinned Tweet
🚨 Live from #ESCCongress + now online in @CircAHA 🚨
ahajournals.org/eprint/IMVYI…
Honored to present our work on Intermediate-Effect Variants (IEVs) in HCM, selected for the Young Investigator Award. 🏆
60% of HCM cases G (-).
Maybe we’ve been looking in the wrong place… 👇🧵
Juan Pablo Ochoa retweeted
As a first-timer at @ISA_Amyloidosis, I was honoured to deliver 4 presentations on ongoing #ATTR projects and to receive the #ISA2026 Presidential Award ✨️
So glad to share this with my fellow-friends and mentors 🥹
Juan Pablo Ochoa retweeted
🧵 Happy to present the results of our study on genetic retesting in hypertrophic cardiomyopathy (HCM), published in the European Heart Journal. What can retesting reveal after a negative result?
doi.org/10.1093/eurheartj/eh…
1/ New paper in Circ Genom Precis Med 🧬
Why do two people with the same MYBPC3 variant have such different hypertrophic cardiomyopathy?
Part of the answer: what else they carry in their genome. 🧵
8/ Led by first author Soledad García Hernandez, with CNIC, Health in Code and colleagues across many centres.
📄 doi.org/10.1161/CIRCGEN.126.…
1
5
178
Juan Pablo Ochoa retweeted
Important data on MYBPC related HCM and the genetic architecture of a large cohort of patients including compound heterozygous variants
ahajournals.org/doi/10.1161/…
Juan Pablo Ochoa retweeted
Imponente Simposium de Genética Cardiovascular con María Sabater, M. Valverde y J.P Ochoa. "La mejor sesión del congreso" E. Villacorta y ML Peña
Juan Pablo Ochoa retweeted
Great discussion on Genetics in #HCM 🫀🧬 by @jpocardio and @fdefrutossemi.
'Do not mix uncertainty with effect'!
The importance of pursuing the genetic cause for #HCM families and reviewing variant classification‼️
Juan Pablo Ochoa retweeted
Variantes de efecto intermedio en miocardiopatía hipertrófica por el Dr Juan Pablo Ochoa 🧬❤️ @SAC_54 @jpocardio
Juan Pablo Ochoa retweeted
En medicina (y en la vida), nos encantan las categorías claras.
✅ Positivo vs. Negativo ❌
✅ Leve vs. Grave ❌
✅ Normal vs. Patológico ❌
Pero la realidad rara vez es tan ordenada.
Entre los extremos, hay grises que muchas veces pasamos por alto. Porque incomodan, porque no ofrecen certezas inmediatas.
1/6👇
Juan Pablo Ochoa retweeted
Replying to @RevEspCardiol
Gracias @health_in_code por una base de datos que permite
análisis así. Y por supuesto al equipo de cardio y resto de autores!! ❤️🙌🏻 @ivonnecardenasr @jpocardio
Juan Pablo Ochoa retweeted
Resultados preliminares de una nueva terapia génica en MCH por MYBPC3
secardiologia.es/blog/16151-…
Juan Pablo Ochoa retweeted
.@peiro_belen: "Las variantes de efecto intermedio emergen como un componente clave en la arquitectura genética de la miocardiopatía hipertrófica, aportando nuevos elementos al modelo clásico centrado en las variantes monogénicas". #BlogSEC @jovenesSEC ow.ly/QxZ350XCARB




























